Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica

Trial Profile

Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ruxolitinib (Primary)
  • Indications Necrobiosis lipoidica
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Mar 2023 Results characterizing the effects of ruxolitinib in NL using transcriptomic analysis, presented at the American Academy of Dermatology annual Meeting 2023
    • 17 Mar 2022 Status changed from active, no longer recruiting to completed.
    • 27 Dec 2021 Planned End Date changed from 1 Feb 2022 to 14 Mar 2022.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top